Detalhe da pesquisa
1.
AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.
Blood
; 138(3): 246-258, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292322
2.
AID in Antibody Diversification: There and Back Again.
Trends Immunol
; 41(7): 586-600, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434680
3.
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.
Blood
; 133(19): 2056-2068, 2019 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30814061
4.
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 69(5): 813-824, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055920
5.
S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progression.
Blood
; 130(6): 777-788, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596424
6.
AID in Antibody Diversification: There and Back Again: (Trends in Immunology 41, 586-600; 2020).
Trends Immunol
; 42(1): 89, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203546
7.
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL.
Br J Haematol
; 182(4): 521-525, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29953583
8.
B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1.
Front Immunol
; 15: 1353138, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529289
9.
AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination.
Sci Adv
; 8(34): eabq0008, 2022 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001653